Pacific Edge Ltd. | Balance Sheet

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
20,534.40
7,935.60
24,316.10
14,724.00
16,399.00
13,012
Total Accounts Receivable
574.20
2,583.80
5,730.00
663.00
1,064.00
1,265
Inventories
241.80
622.90
707.30
824.00
752.00
842
Other Current Assets
75.90
128.60
339.90
330.00
315.00
445
Total Current Assets
21,426.30
11,271.00
31,093.30
16,541.00
18,530.00
15,564
Net Property, Plant & Equipment
1,112.00
1,118.30
989.90
837.00
854.00
769
Intangible Assets
192.90
244.10
247.60
329.00
281.00
233
Total Assets
22,731.20
12,633.30
32,330.80
17,707.00
19,665.00
16,566
ST Debt & Current Portion LT Debt
-
-
-
-
73.00
Accounts Payable
619.80
949.90
1,114.30
838.00
665.00
Other Current Liabilities
333.40
980.90
1,409.00
1,896.00
2,261.00
Total Current Liabilities
953.20
1,930.80
2,523.30
2,734.00
2,999.00
Long-Term Debt
-
-
-
-
26.00
Total Liabilities
953.20
1,930.80
2,523.30
2,734.00
3,025.00
Common Equity (Total)
21,778.00
10,702.50
29,807.50
14,973.00
16,640.00
Total Shareholders' Equity
21,778.00
10,702.50
29,807.50
14,973.00
16,640.00
Total Equity
21,778.00
10,702.50
29,807.50
14,973.00
16,640.00
Liabilities & Shareholders' Equity
22,731.20
12,633.30
32,330.80
17,707.00
19,665.00

About Pacific Edge

View Profile
Address
Centre for Innovation
Dunedin OT 9016
New Zealand
Employees -
Website http://www.pacificedgedx.com
Updated 07/08/2019
Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide.